Sunil Panchal, MD
Interventional Pain Medicine · Lutz, FLNPI 1437112810
Payments from drug & device makers
What this record shows
This record is dominated by other: $315,037 of the $363,447 with a category attached, or 86.7%. Curonix LLC accounts for 86.7% of it on its own, with 52 other manufacturers making up the rest. Reporting peaked in 2022 at $317,581 and has fallen 98.4% since, to $5,232 in 2025. Among interventional pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 377 payments — averaging $964.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Curonix LLC$315K
- Stimwave Technologies Incorporated$17K
- Boston Scientific$6K
- Surgalign Spine Technologies, Inc.$5K
- Saluda Medical Americas, Inc.$3K
- Camber Spine Technologies LLC$2K
- plus $16K from 47 others
What the payments were for
- Consulting fees$11,0003%
- Speaking & faculty fees$1,5000%
- Travel & lodging$15,5014%
- Food & beverage$19,3525%
- Gifts$2390%
- Entertainment$8170%
- Other$315,03787%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- StimQ Receiver Stimulator Kit Channel A US w Receiver$315,000
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$315,000
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$315,000
- Freedom 4A Receiver Kit Channel A US w Receiver$315,000
- Freedom 8A Receiver Kit Channel A US w Receiver$315,000
- SlMMETRY$4,250
- WaveWriter Alpha Prime 16$2,695
- Evoke SCS$2,130
- BELBUCA$1,500
- MYSPINE$1,266
- Intracept$1,121
- IFUSE IMPLANT SYSTEM$796
- InSpan$624
- Sacrix$624
- HA MINUTEMAN G3-R$547
- Omnia$514
- Joline Kyphoplasty System Allevo$421
- INTELLIS ADAPTIVESTIM$329
- Evoke$329
- GENERAL PAIN MANAGEMENT$275
How this compares
$363,447 in reported general payments places this provider in the 95th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 12 | $9,839 |
| Xtampza ErOxycodone Myristate | 15 | $7,745 |
| Morphine Sulfate ErMorphine Sulfate | 135 | $4,576 |
| Gabapentin | 172 | $2,929 |
| Lidocaine | 11 | $2,783 |
| Tizanidine Hcl | 105 | $2,694 |
| Tramadol Hcl | 157 | $1,931 |
| Methadone Hcl | 27 | $852 |
| Baclofen | 39 | $809 |
| Pregabalin | 39 | $773 |
| Celecoxib | 47 | $605 |
| Topiramate | 56 | $403 |
| Cephalexin | 34 | $283 |
| Meloxicam | 16 | $55 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Xtampza Er | $14 | $17,58427 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in Lutz
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
- Miguel de la GarzaNew Port Richey$138K
- Andrea TrescotEast Palatka$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.